The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Histiocytoma, Malignant Fibrous

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Histiocytoma, Malignant Fibrous


High impact information on Histiocytoma, Malignant Fibrous


Chemical compound and disease context of Histiocytoma, Malignant Fibrous


Biological context of Histiocytoma, Malignant Fibrous


Anatomical context of Histiocytoma, Malignant Fibrous


Gene context of Histiocytoma, Malignant Fibrous


Analytical, diagnostic and therapeutic context of Histiocytoma, Malignant Fibrous


  1. p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Leach, F.S., Tokino, T., Meltzer, P., Burrell, M., Oliner, J.D., Smith, S., Hill, D.E., Sidransky, D., Kinzler, K.W., Vogelstein, B. Cancer Res. (1993) [Pubmed]
  2. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Wiechen, K., Sers, C., Agoulnik, A., Arlt, K., Dietel, M., Schlag, P.M., Schneider, U. Am. J. Pathol. (2001) [Pubmed]
  3. Biomaterial-induced sarcoma: A novel model to study preneoplastic change. Kirkpatrick, C.J., Alves, A., Köhler, H., Kriegsmann, J., Bittinger, F., Otto, M., Williams, D.F., Eloy, R. Am. J. Pathol. (2000) [Pubmed]
  4. Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas. Takahiro, T., Shinichi, K., Toshimitsu, S. Clin. Cancer Res. (2003) [Pubmed]
  5. A histiocyte-specific marker in the diagnosis of malignant fibrous histiocytoma. Use of monoclonal antibody KP-1 (CD68). Binder, S.W., Said, J.W., Shintaku, I.P., Pinkus, G.S. Am. J. Clin. Pathol. (1992) [Pubmed]
  6. Hsp27 expression in neuroblastoma: correlation with disease stage. Ungar, D.R., Hailat, N., Strahler, J.R., Kuick, R.D., Brodeur, G.M., Seeger, R.C., Reynolds, C.P., Hanash, S.M. J. Natl. Cancer Inst. (1994) [Pubmed]
  7. Malignant fibrous histiocytomas induced by 4-(hydroxyamino)quinoline 1-oxide in rats. Konishi, Y., Maruyama, H., Mii, Y., Miyauchi, Y., Yokose, Y., Masuhara, K. J. Natl. Cancer Inst. (1982) [Pubmed]
  8. Carcinogenicity of tannin and tannin-free extracts of bracken fern (Pteridium aquilinum) in rats. Pamukcu, A.M., Wang, C.Y., Hatcher, J., Bryan, G.T. J. Natl. Cancer Inst. (1980) [Pubmed]
  9. The value of high-dose methotrexate-based neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone. Ham, S.J., Hoekstra, H.J., van der Graaf, W.T., Kamps, W.A., Molenaar, W.M., Schraffordt Koops, H. J. Clin. Oncol. (1996) [Pubmed]
  10. 2B1 antigen characteristically expressed on extracellular matrices of human malignant tumors is a large chondroitin sulfate proteoglycan, PG-M/versican. Isogai, Z., Shinomura, T., Yamakawa, N., Takeuchi, J., Tsuji, T., Heinegård, D., Kimata, K. Cancer Res. (1996) [Pubmed]
  11. Malignant fibrous histiocytoma: etiology for a cold defect on technetium-99m-methylene diphosphonate bone scan. Sanders, T.G., Wilf, L.H., Northup, H.M. J. Nucl. Med. (1990) [Pubmed]
  12. Gallium-67 uptake by a malignant fibrous histiocytoma: case report. Harrowe, D.J., Kessler, S., Jansen, A.A., Larson, S.M. J. Nucl. Med. (1976) [Pubmed]
  13. Carcinogenicity of dinitropyrenes in the weanling female CD rat. Imaida, K., Lee, M.S., Wang, C.Y., King, C.M. Carcinogenesis (1991) [Pubmed]
  14. Angiomatoid "malignant fibrous histiocytoma": an immunohistochemical study indicative of myoid differentiation. Fletcher, C.D. Hum. Pathol. (1991) [Pubmed]
  15. Enhanced photodynamic destruction of a transplantable fibrosarcoma using photochemical internalisation of gelonin. Dietze, A., Peng, Q., Selbo, P.K., Kaalhus, O., Müller, C., Bown, S., Berg, K. Br. J. Cancer (2005) [Pubmed]
  16. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma. Kuroda, M., Ishida, T., Horiuchi, H., Kida, N., Uozaki, H., Takeuchi, H., Tsuji, K., Imamura, T., Mori, S., Machinami, R. Am. J. Pathol. (1995) [Pubmed]
  17. Aberration of epidermal growth factor receptor expression in bone and soft-tissue tumors: protein overexpression, gene amplification and activation of downstream molecules. Dobashi, Y., Takei, N., Suzuki, S., Yoneyama, H., Hanawa, M., Ooi, A. Mod. Pathol. (2004) [Pubmed]
  18. Expression of the transin, c-fos, and c-jun genes in rat transplantable osteosarcomas and malignant fibrous histiocytomas. Honoki, K., Tsutsumi, M., Tsujiuchi, T., Kondoh, S., Shiraiwa, K., Miyauchi, Y., Mii, Y., Tamai, S., Konishi, Y., Bowden, G.T. Mol. Carcinog. (1992) [Pubmed]
  19. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases. Li, X.Q., Hisaoka, M., Shi, D.R., Zhu, X.Z., Hashimoto, H. Hum. Pathol. (2004) [Pubmed]
  20. Experimental induction of rhabdomyosarcoma in mice with fractionated doses of beta-irradiation. Gupta, A., Andrews, K.L., McDaniel, K.M., Nagle, R.B., Bowden, G.T. J. Cancer Res. Clin. Oncol. (1999) [Pubmed]
  21. Monoclonal antibody identification and characterization of two human sarcoma-associated antigens. Stastny, J.J., Brown, J.M., Beattie, C.W., Das Gupta, T.K. Cancer Res. (1991) [Pubmed]
  22. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line. Nakanishi, H., Yoshioka, K., Joyama, S., Araki, N., Myoui, A., Ishiguro, S., Ueda, T., Yoshikawa, H., Itoh, K. Am. J. Pathol. (2004) [Pubmed]
  23. Proteins of intermediate filaments. An immunohistochemical and biochemical approach to the classification of soft tissue tumors. Denk, H., Krepler, R., Artlieb, U., Gabbiani, G., Rungger-Brändle, E., Leoncini, P., Franke, W.W. Am. J. Pathol. (1983) [Pubmed]
  24. A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms: strong clusterin immunostaining is highly specific for follicular dendritic cell tumor. Grogg, K.L., Macon, W.R., Kurtin, P.J., Nascimento, A.G. Mod. Pathol. (2005) [Pubmed]
  25. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Cessna, M.H., Zhou, H., Sanger, W.G., Perkins, S.L., Tripp, S., Pickering, D., Daines, C., Coffin, C.M. Mod. Pathol. (2002) [Pubmed]
  26. Analysis of p53 and mdm2 proteins in malignant fibrous histiocytoma in absence of gene alteration: prognostic significance. Molina, P., Pellín, A., Navarro, S., Boix, J., Carda, C., Llombart-Bosch, A. Virchows Arch. (1999) [Pubmed]
  27. Immunohistochemical detection of HER-2/neu, c-kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas. Potti, A., Ganti, A.K., Foster, H., Knox, S., Hebert, B.J., Tendulkar, K., Sholes, K., Koch, M., Kargas, S. Anticancer Res. (2004) [Pubmed]
  28. S100A6 expression in fibrohistiocytic lesions. Fullen, D.R., Reed, J.A., Finnerty, B., McNutt, N.S. J. Cutan. Pathol. (2001) [Pubmed]
  29. Chemotherapeutic potential of plant alkaloids and multidrug resistance mechanisms in malignant fibrous histiocytoma of the heart. Reinecke, P., Steckstor, M., Schmitz, M., Gabbert, H.E., Gerharz, C.D. Oncol. Rep. (2004) [Pubmed]
  30. Expression of betacellulin, heparin-binding epidermal growth factor and epiregulin in human malignant fibrous histiocytoma. Yamamoto, T., Akisue, T., Marui, T., Nakatani, T., Kawamoto, T., Hitora, T., Nagira, K., Fujita, I., Matsumoto, K., Kurosaka, M. Anticancer Res. (2004) [Pubmed]
  31. Flow cytometric DNA analysis of malignant fibrous histiocytoma and related fibrohistiocytic tumors. Radio, S.J., Wooldridge, T.N., Linder, J. Hum. Pathol. (1988) [Pubmed]
  32. Expression of the tissue metalloproteinase inhibitors TIMP-1 and TIMP-2 in malignant fibrous histiocytomas and dermatofibromas as studied by in situ hybridization and immunohistochemistry. Hurskainen, T., Soini, Y., Tuuttila, A., Höyhtyä, M., Oikarinen, A., Autio-Harmainen, H. Hum. Pathol. (1996) [Pubmed]
  33. Continuous intratumoral microdialysis during high-dose methotrexate therapy in a patient with malignant fibrous histiocytoma of the femur: a case report. Ekstrøm, P.O., Andersen, A., Saeter, G., Giercksky, K.E., Slørdal, L. Cancer Chemother. Pharmacol. (1997) [Pubmed]
  34. Malignant fibrous histiocytoma developing in irradiated sacral chordoma. Halpern, J., Kopolovic, J., Catane, R. Cancer (1984) [Pubmed]
  35. Multiple primary malignant fibrous histiocytoma of the stomach and small intestine. Shibuya, H., Azumi, N., Onda, Y., Abe, F. Acta Pathol. Jpn. (1985) [Pubmed]
WikiGenes - Universities